9-Oct-2026
No headlines found.
CEO Litz Van Dyke Reflects on 10 Years with Carter Bank
ACCESS Newswire (Thu, 24-Sep 10:30 AM ET)
Carter Bank Strengthens Raleigh Presence with Commercial Banking Leader Kevin Lockhart
Business Wire (Tue, 15-Sep 9:00 AM ET)
Carter Bankshares, Inc. Establishes Dividend Reinvestment and Stock Purchase Plan
ACCESS Newswire (Tue, 11-Aug 4:34 PM ET)
Carter Bankshares, Inc. Declares Quarterly Dividend
ACCESS Newswire (Thu, 23-Jul 8:45 AM ET)
Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results
ACCESS Newswire (Thu, 23-Jul 8:00 AM ET)
Carter Bank Named Best Bank in Virginia by Forbes
ACCESS Newswire (Tue, 14-Jul 9:00 AM ET)
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
Carter Bankshares trades on the NASDAQ stock market under the symbol CARE.
As of October 9, 2026, CARE stock price declined to $30.16 with 154,681 million shares trading.
CARE has a beta of -0.20, meaning it tends to be less sensitive to market movements. CARE has a correlation of 0.01 to the broad based SPY ETF.
CARE has a market cap of $698.62 million. This is considered a Small Cap stock.
Last quarter Carter Bankshares reported $45 million in Revenue and $.53 earnings per share. This fell short of revenue expectation by $-13 million and exceeded earnings estimates by $.11.
In the last 3 years, CARE traded as high as $36.06 and as low as $10.43.
The top ETF exchange traded funds that CARE belongs to (by Net Assets): AVUV, VTI, IWM, KRE, DFSV.
CARE has outperformed the market in the last year with a return of +56.3%, while the SPY ETF gained +16.8%. However, in the most recent history, CARE shares have underperformed the stock market with its stock returning -4.2% in the last 3 month period and +0.3% for the last 2 week period, while SPY has returned +4.7% and +1.5%, respectively.
CARE support price is $29.99 and resistance is $30.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CARE shares will trade within this expected range on the day.